One of our partners, ‘Quotient Sciences’ is dedicated to accelerating the development of new drugs for patients around the world, providing CRO and CDMO services including formulation development, clinical pharmacology trials, and clinical and commercial manufacturing services to the pharmaceutical and biotech industry. Within the drug development landscape Quotient are well known for their translational pharmaceutics and RapidFACT programs.

For today’s free content, we wanted to share a presentation deck titled “Using RapidFACT® and pharmaceutical design spaces to optimize drug products across the development life cycle” from John McDermott at Quotient Sciences. Mr McDermott delivered this talk at one of our past Controlled & Modified Drug Release Summits. This presentation will give a brief overview of it’s RapidFACT program with it’s formulation design space concepts and opportunities, as well as presenting multiple case study examples of success.

Scroll through the presentation below……